More women in the UK are attempting IVF in their forties than at any point in the history of the treatment. The decisions involved — about NHS eligibility, the clinical realism of success with own eggs versus donor eggs, and the financial planning required for a pathway that may involve multiple cycles and a change of approach — are consequential and often made with incomplete information.

This guide covers what you actually need to know.

What the HFEA Data Shows

The HFEA publishes clinic-level outcome data annually. The 2024 dataset shows the following approximate live birth rates per embryo transfer for IVF using the patient's own eggs:

  • Under 35: approximately 32%
  • 35–37: approximately 25%
  • 38–39: approximately 18%
  • 40–42: approximately 10–12%
  • 43–44: approximately 5%
  • 45 and over: below 3%

These are per-transfer rates — not per-cycle rates, and not per-woman rates. The distinction matters. The probability that any given woman will have a live birth from a multi-cycle IVF pathway is higher than these per-transfer figures suggest, because multiple transfers from one retrieval, or multiple retrieval cycles, multiply the individual attempt probabilities.

However, the age-related decline is real and steep. For a woman aged 43 using her own eggs, the per-transfer live birth rate is approximately the same as the chance of a single dice roll landing on a six.

NHS Access After 40

NICE Guideline NG65 recommends one funded IVF cycle for women aged 40–42 who meet specific clinical criteria: they have not previously had NHS IVF, they have no known low ovarian reserve (as measured by AMH or AFC), and they are aware that the evidence for success in this age group is less strong than for younger women.

In practice, NHS IVF access after 40 varies significantly by ICB:

  • Some ICBs follow NICE exactly, funding one cycle up to age 42
  • Some set a lower upper limit (38, 39, or 40) and do not fund treatment after that age
  • Some apply more restrictive clinical criteria alongside the age threshold

For a full breakdown of how age limits vary by ICB, see NHS IVF age limits by ICB. For detail on the appeals process if you believe you have been incorrectly refused, see how to appeal an NHS IVF refusal.

The AMH Question After 40

After 40, AMH levels are typically lower than in younger women — this is expected and reflects normal age-related decline in ovarian reserve. Some ICBs set AMH thresholds that, when applied to women in their early forties, effectively exclude many of them regardless of other clinical factors.

If your AMH is being used as a reason for refusal, see AMH and NHS IVF eligibility for guidance on challenging that decision.

Donor Eggs: When and Why Clinics Recommend Them

For women over 43 using their own eggs, most clinics — and most evidence — would suggest that donor eggs represent a more effective use of financial and emotional resources.

Donor egg IVF uses eggs from a younger donor, typically under 35, fertilised with the partner's or donor's sperm and transferred to the recipient's uterus. Success rates for donor egg IVF are significantly higher than those for own-egg IVF at the same recipient age — because the outcome is primarily driven by egg quality, which is a function of the donor's age, not the recipient's.

HFEA data for 2024 shows live birth rates per transfer for donor egg IVF at approximately 28–32% across all recipient ages, compared to the 5–10% for own-egg IVF in the 43–44 age group.

The key practical questions about donor eggs in the UK:

  • Waiting times are long. UK egg donors are in short supply; waiting times at NHS and private clinics are frequently one to three years.
  • Donor eggs are not typically NHS-funded — some ICBs fund donor egg IVF, but this is less common than funding for own-egg IVF.
  • Going abroad for donor eggs is a common option for UK patients — see IVF abroad vs the UK for a cost and quality comparison.

Financial Planning for IVF After 40

The financial picture for IVF after 40 is different from IVF at younger ages, for two reasons:

Success rates are lower, meaning the expected number of cycles to achieve a live birth is higher. Donor eggs — if that route is taken — cost significantly more per cycle than own-egg IVF.

A realistic financial plan should model several scenarios:

Scenario 1: Own-egg IVF, one NHS cycle followed by private cycles. If your ICB funds one cycle, start there. A private own-egg IVF cycle in the UK costs £8,000–£15,000 all-in. With a per-transfer success rate of approximately 10–12% at age 40–42, a realistic expectation for the number of transfers needed is high.

Scenario 2: Own-egg IVF abroad. Overseas own-egg IVF costs £6,000–£12,000 all-in including travel. The saving per cycle is meaningful over a multi-cycle pathway.

Scenario 3: Donor egg IVF. UK donor egg IVF (private) costs £10,000–£18,000 per cycle. Donor egg IVF abroad costs £7,000–£12,000. With higher per-transfer success rates, the expected total spend to achieve a live birth may be comparable or lower than a multi-cycle own-egg pathway.

For a breakdown of cost comparison across these scenarios, see IVF costs in the UK: a complete 2026 breakdown. For financing options, see IVF loans versus clinic payment plans.

How to Read Clinic Success Rate Claims After 40

Clinics sometimes present success rates in ways that are misleading for patients in their forties. Common forms:

"Positive pregnancy rate" is not the same as live birth rate. A positive beta-hCG test does not mean the pregnancy will continue.

Per embryo transfer rate (what HFEA reports) is lower than per-woman rate (which accounts for multiple attempts). Clinics using per-woman cumulative rates over multiple attempts will report higher figures.

Age group aggregation. A clinic reporting a 15% success rate for "over 40" patients is averaging across 40–44. A 41-year-old's outcomes are meaningfully different from a 44-year-old's.

For a full guide to interpreting HFEA data correctly, see HFEA success rates explained.

Questions to Ask Your Clinic Before Starting

If you are over 40 and exploring IVF:

  1. What is your clinic's live birth rate per embryo transfer for my specific age group, using my own eggs?
  2. At what point — clinically and statistically — do you recommend transitioning to donor eggs?
  3. What does my AMH and AFC suggest about the likely number of eggs at retrieval?
  4. How many embryos do you typically expect to create from a cycle with my profile?
  5. What is your embryo freezing and FET protocol, and what are the costs?
  6. What is the total all-in cost, including medication, for a complete cycle?

Frequently Asked Questions

Q: Can I get NHS IVF at age 41?

A: In some areas, yes. NICE recommends one funded cycle for women aged 40–42 who meet clinical criteria. However, many ICBs set a lower upper limit. Check your ICB's current policy at nestie.co/nhs or see NHS IVF age limits by ICB.

Q: Should I try own-egg IVF first or go straight to donor eggs at 43?

A: This is a clinical and personal decision. Statistically, per-transfer live birth rates with own eggs at 43 are approximately 5%. Donor egg success rates are significantly higher. Many clinicians would recommend discussing donor eggs as a primary route at this age, but some patients — for personal, ethical, or financial reasons — prefer to attempt own-egg cycles first. The key is to make the decision with accurate information, not optimistic clinic marketing.

Q: How long is the waiting list for donor eggs in the UK?

A: Waiting times vary by clinic but are frequently one to three years for NHS-funded donor egg cycles. Private waiting lists are shorter but still significant. Many patients in this situation consider overseas treatment — see IVF abroad vs the UK.

Q: Does age affect IVF success with donor eggs?

A: Much less so than with own eggs, because success is primarily driven by the donor's egg quality. Recipient age does have some impact on uterine environment and implantation, but the effect is smaller and the overall success rates for donor egg IVF remain meaningful well into the mid-forties.

Q: My clinic is recommending several add-on treatments. Are they worth it at my age?

A: The evidence base for most IVF add-ons does not show improved outcomes specifically for older patients. The HFEA's traffic light system rates most add-ons as amber or red. Ask your clinic specifically what evidence supports the recommendation in your case, and read IVF add-on treatments and the evidence before committing.

This article is for information only and does not constitute medical or legal advice. Success rates change as HFEA data is updated annually; always discuss your specific clinical situation with a qualified fertility specialist.